Health Catalyst (HCAT) Aktie Kurs

Health Catalyst Kurs

NASDAQ·LUKKET
1,31
​
Markedet lukket

Omsætningen er vokset med 19,1 % om året de seneste 8 år til 286,88 Mio. USD. Health Catalysts nettoavance ligger på -62,0 %, op fra -68,2 % for flere år siden. Analytikernes mediankursmål er 2,38 USD, hvilket er over den aktuelle kurs med 81,3 %. Af 11 analytikere anbefaler 6 køb — den samlede vurdering er Køb.

Health Catalyst aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Health Catalyst aktie og aktieanalyse

Health Catalyst Inc. er en amerikansk virksomhed, der specialiserer sig i analyse og styring af sundhedsdata. Virksomheden blev grundlagt i 2008 af Tom Burton, Steve Barlow og Dale Sanders i Salt Lake City og har siden gennemgået en imponerende vækst. Historien om Health Catalyst begyndte med målet om at skabe et bedre sundhedssystem baseret på stærk dataanalyse og datadrevne beslutninger. Grundlæggerne indså, at manglen på dataanalyse og konsekvent dataproduktionskvalitet inden for sundhedssektoren førte til ineffektive processer og høje omkostninger. Virksomheden tog fat på at løse disse problemer og bidrage til bedre patientpleje og omkostningsbesparelser. Health Catalyst er opdelt i flere divisioner for at tilbyde et bredt spektrum af løsninger til sundhedssektoren. Disse omfatter områderne data- og analytiske platforme, klinisk beslutningsstøtte, population health management samt medicinsk billedbehandling. Health Catalysts platform tilbyder omfattende dataanalyse og procesforbedringer i centrale forretningsområder for at understøtte høj kvalitet i sundhedsydelserne. Inden for klinisk beslutningsstøtte leverer Health Catalyst analyse og værktøjer til at træffe kliniske beslutninger baseret på data og evidensbaseret medicin. Health Catalysts division for Population Health Management hjælper forsikringsselskaber og sundhedsudbydere med at optimere håndteringen af befolkningshelbredet baseret på dataanalyse for at opnå bedre resultater med reducerede omkostninger. Inden for medicinsk billedbehandling tilbyder Health Catalyst løsninger til at forbedre workflow-integration og kvalitetsforbedringer for medicinske billeder og data. Health Catalysts produkter inkluderer Analytics-platformen, en omfattende platform til styring af sundhedsdata til kliniske, økonomiske og operationelle beslutningstagning. Health Catalysts kliniske workflow-applikationer understøtter læger og sygeplejersker i at træffe informerede beslutninger og yde optimal pleje til patienterne. Health Catalysts produktlinje til Population Health Management giver værktøjer til risikovurdering, analyse af befolkningshelbred og klinisk beslutningsstøtte til forsikringsselskaber og sundhedsudbydere. Health Catalysts forretningsmodel er baseret på salg af softwareprodukter, tjenester og abonnementer til brug af sundhedsdataanalytikplatformen. Virksomheden henvender sig til et bredt kundesegment, herunder hospitaler, klinikker, sundhedsudbydere, forsikringsselskaber og statlige myndigheder. Health Catalyst har udviklet sig til en førende udbyder af analytics og beslutningsstøttesystemer til sundhedsdata. Virksomheden har opbygget et globalt tilstedeværelse ved at tilbyde løsninger til sundhedsvirksomheder verden over. Health Catalyst har blevet en stærk innovator i branchen ved at udvikle innovative teknologier og integrere indsigt fra sin omfattende dataanalyse i kliniske og operationelle beslutninger. Samlet set har Health Catalyst en stærk vision for fremtidens sundhedsvæsen. Virksomheden hjælper med at overvinde de mange udfordringer i sundhedssektoren ved at fokusere på dataanalyse og evidensbaseret beslutningstagning. Health Catalysts innovative teknologier og løsninger forventes at bidrage til at forbedre sundhedsydelserne og gøre dem mere omkostningseffektive i de kommende år.

Hyppigt stillede spørgsmål om Health Catalyst-aktien

The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.

Health Catalyst Inc is primarily active in the healthcare industry.

Some of the main competitors of Health Catalyst Inc in the market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, and McKesson Corporation.

Health Catalyst Inc is a leading provider of data and analytics in the healthcare industry. Founded in 2008, the company has quickly gained prominence for its innovative approach to improving healthcare outcomes through data-driven insights. Health Catalyst offers a comprehensive suite of solutions designed to help healthcare organizations organize, analyze, and leverage their data to drive decision-making and improve patient care. With a strong focus on value-based care and population health management, Health Catalyst has established itself as a trusted partner for healthcare organizations seeking to transform their operations and achieve better patient outcomes.

Health Catalyst Inc, a leading healthcare analytics and data warehousing company, has achieved several significant milestones. Notably, the company successfully completed its initial public offering in July 2019, raising approximately $182 million. In 2020, Health Catalyst was named one of the Best Places to Work in Healthcare by Modern Healthcare. Furthermore, the company has consistently expanded its customer base, delivering data-driven solutions to over 150 healthcare organizations. Health Catalyst's innovative use of artificial intelligence and machine learning technologies has also gained recognition, contributing to the company's growth and success in improving healthcare outcomes.

Health Catalyst Inc is primarily present in the United States.

Health Catalyst Inc is a leading provider of data and analytics solutions for healthcare organizations. The company represents values such as innovation, collaboration, and a patient-centric approach. With a focus on improving healthcare outcomes, Health Catalyst Inc emphasizes the importance of data-driven decision-making and empowering healthcare professionals with actionable insights. Their corporate philosophy revolves around driving meaningful change in the healthcare industry through leveraging advanced analytics and technology. By offering transformative solutions, Health Catalyst Inc aims to enable healthcare organizations to deliver better patient care, reduce costs, and enhance operational efficiency.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 2,38 USD for Health Catalyst-aktien (median: 2,38 USD), svarende til +81,7 % i forhold til seneste kurs. Konsensus bygger på 11 analytikervurderinger.

11 analytikere vurderer i øjeblikket Health Catalyst-aktien: 6 anbefaler køb, 5 hold og 0 salg. For 2026 forventer analytikere, at Health Catalyst genererer omsætning på 247,90 Mio. USD og indtjening pr. aktie på -0,04 USD.

Omregnet til den aktuelle valutakurs handles Health Catalyst-aktien til 1,19 EUR (1,31 USD).

Health Catalyst-aktien (HCAT) er noteret på 2 børser, herunder: NASDAQ (HCAT), Frankfurt (2YP.F).

Health Catalyst Inc is a US-based company specializing in the development of clinical analytics platforms. The company offers solutions for healthcare data analysis and data-driven decision support. Its business model is based on providing software and analytics tools to manage, integrate, analyze, and visualize clinical data. By combining the latest technologies in data analytics and business intelligence with deep expertise in healthcare, Health Catalyst supports hospitals and health systems in improving patient care. The company consists of two main divisions: data warehousing and analytics. The data warehousing division involves developing and managing databases and integrating data from various sources to obtain a comprehensive view of a facility's clinical performance and enable informed decision-making. The analytics division focuses on implementing analytics tools and methods to analyze the collected data and transform it into meaningful insights. Health Catalyst's product range includes solutions for population health management, improving clinical outcomes, and reducing healthcare costs. This includes clinical analytics and visualization tools, population health management platforms, data integration and storage solutions, and healthcare analytics services. The Health Catalyst data platform is an open system capable of processing both structured and unstructured data in real-time. This allows customers to easily integrate and analyze their data for informed decision-making. The target customers of Health Catalyst are hospitals and health systems in the United States facing increasing competitive pressure and growing demand for high-quality patient care. The company addresses the need to reduce healthcare costs, improve patient care, and optimize health processes. Health Catalyst's business model relies on recurring revenue from selling subscriptions to use the software platform and providing analytics tools and services. Additionally, the company offers training, consulting services, and technical support. In summary, Health Catalyst creates value for its customers by providing advanced tools to improve healthcare and achieve cost savings. The company's business model is also focused on recurring subscription revenue and additional service fees. By focusing on improving clinical outcomes, Health Catalyst demonstrates enthusiasm for healthcare and a passionate commitment to enhancing patient well-being.

forventet-omsætningen for Health Catalyst er 247,90 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

forventet-overskuddet for Health Catalyst er -3,03 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Health Catalyst er i øjeblikket -30,73. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Health Catalyst-aktien.

Pris-til-salgs-forholdet (P/S) for Health Catalyst er i øjeblikket 0,38. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Health Catalyst-aktien.

AlleAktien-kvalitetsscore for Health Catalyst er 2/10.

ISIN for Health Catalyst er US42225T1079. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Health Catalyst er A2PH3J. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Health Catalyst er HCAT. Tickersymbolet bruges til at handle Health Catalyst-aktier på børsen.

Fair værdiTerminal
1,13 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Sundhedsteknologi
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
239.068,35 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Land
Valuta
USD
Børsintroduktion
25. jul. 2019
ISIN
US42225T1079
CUSIP
42225T107
SEDOL
BKLCX50
Markedsværdi
52-ugers interval
AAQS
2 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2026
-30,73
P/Ee 2027
-26,95
P/Ee 2028
16,37
P/S
P/Se
0,38
EV/EBIT
—
K/B-forhold
0,37
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-42,68 %
Sidst opdateret 22. nov. 2026, 05.19

Health Catalyst Ticker

FRANKFURT · 2YP.FNASDAQ · HCAT

Health Catalyst FIGI

HCAT:US · BBG00LDPZMS6HCAT:UA · BBG00P1J0C77HCAT:UC · BBG00P1J0C86HCAT:UN · BBG00P1J0CB2HCAT:UP · BBG00P1J0CC1HCAT:UB · BBG00P1J0CF8HCAT:UM · BBG00P1J0CH6HCAT:UX · BBG00P1J0CJ4HCAT:UD · BBG00P1J0CP7HCAT:UW · BBG00P1J0CR5HCAT:UF · BBG00P1J0CS4HCAT:VY · BBG00P1J0CT3